Michael Lansing
Pulmonary Disease · Pikesville, MDNPI 1962483230
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $77,150 of the $84,694 with a category attached, or 91.1%. GSK accounts for 97.9% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $61,945 and has fallen 95.7% since, to $2,638 in 2021. Among pulmonary disease clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 201 payments — averaging $421.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$83K
- Boehringer Ingelheim$426
- Insmed, Inc.$270
- Grifols USA, LLC$257
- Mylan Specialty L.p.$239
- AstraZeneca$177
- plus $387 from 13 others
What the payments were for
- Speaking & faculty fees$77,15091%
- Travel & lodging$3,0374%
- Food & beverage$4,5075%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 112 | $82,937 |
| Boehringer Ingelheim | 23 | $426 |
| Insmed, Inc. | 6 | $270 |
| Grifols USA, LLC | 17 | $257 |
| Mylan Specialty L.p. | 13 | $239 |
| AstraZeneca | 8 | $177 |
| Teva Pharmaceuticals USA, Inc. | 4 | $63 |
| Sunovion Pharmaceuticals Inc. | 3 | $46 |
| Genentech USA, Inc. | 2 | $39 |
| Resmed Corp | 2 | $38 |
| Novo Nordisk | 2 | $32 |
| Merck | 2 | $25 |
| Neos Therapeutics, LP | 1 | $25 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $24 |
| Mallinckrodt Enterprises LLC | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Amgen | 1 | $19 |
| Fisher & Paykel Healthcare Inc | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$36,549
- ANORO$31,420
- ANORO ELLIPTA$8,746
- NUCALA$4,000
- Arikayce$120
How this compares
$84,694 in reported general payments places this provider in the 90th percentile of 297 pulmonary disease providers in Maryland.
Other pulmonary disease in Pikesville
- Alan SchwartzBaltimore$1.3M
- Hitesh BatraBaltimore$611K
- Lonny YarmusBaltimore$582K
- Robert WiseBaltimore$389K
- da Wei LiaoBethesda$310K
- Ko Pen WangBaltimore$280K
- Hans LeeBaltimore$277K
- Angela ArgentoBaltimore$269K
- Michael DrummondBaltimore$263K
- Jason AkulianBaltimore$231K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.